Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01469117 · ClinicalTrials.gov registry record
Feeding Trial in Pediatric Patients
A clinical trial of Developmental Disabilities, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT01469117: Completed study of Developmental Disabilities, sponsored by Société des Produits Nestlé (SPN).
NCT01469117 is a study of Developmental Disabilities that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 16 participants, below the 97-participant average among 4 other Developmental Disabilities trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01469117, a study of Developmental Disabilities, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single center, prospective, non-randomized, uncontrolled, observational study of the use of an enteral nutrition product in pediatric patients with developmental disabilities.
Conditions Studied
Interventions
- OTHER enteral formula
Study Locations (1)
Oklahoma
- The Children's Center - Bethany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-11 |
| Est. Completion | 2013-01 |
What the finished NCT01469117 record still lists
NCT01469117 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 97-participant average among 4 other Developmental Disabilities trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Developmental Disabilities appearing as the primary indexed condition, and to 1 intervention - of which enteral formula is the first listed.
NCT01469117 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT01469117 about?
NCT01469117 is a clinical study titled "Feeding Trial in Pediatric Patients". This is a single center, prospective, non-randomized, uncontrolled, observational study of the use of an enteral nutrition product in pediatric patients with developmental disabilities.
What is the current status of trial NCT01469117?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2011-11. Estimated completion is 2013-01.
What conditions does trial NCT01469117 study?
This clinical trial studies the following conditions: Developmental Disabilities.
What interventions are being tested in trial NCT01469117?
The interventions under investigation include: enteral formula (OTHER).
Who is sponsoring clinical trial NCT01469117?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01469117 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Developmental Disabilities
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exploratory Trial of a Pediatric Web-Based Care Planning Guide
ACTIVE NOT RECRUITING · NA
-
Healthy Lifestyles for People With Intellectual Disabilities
COMPLETED · NA
-
Resident Surveillance of Pediatric Patient Developmental Status at the Two Month Preventive Care Visit
COMPLETED · NA
-
Use of an Educational Story to Prepare Children With Developmental Disabilities for Sleep Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia